The current view is that the enrichment of CD8+ T infiltration in the tumor microenvironment is considered to be a reliable basis for the efficacy of immunotherapy; however, the tumor microenvironment in HCC is strongly immunosuppressive. The gene discussed is CD8A; the disease is neoplasm.